Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Allelix reports progress in osteoporosis trial

March 6, 1997

Novel post-Amadori inhibitors identified

March 5, 1997

Novo Nordisk to develop compounds discovered by Indian research foundation

March 5, 1997

GelTex receives U.S. patent for CholestaGel

March 5, 1997

Antidiabetic/hypolipidemic agents from Sumitomo Metal

March 5, 1997

Pfizer develops ACAT inhibitors

March 5, 1997

First launch for troglitazone

March 4, 1997

Pramlintide delays gastric emptying in IDDM

March 4, 1997

Comparative efficacy and tolerance of s.c. and i.m. Puregon

March 4, 1997

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...